These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12821534)

  • 1. Cancer genetics or cancer genomics in the era of genomic medicine?
    Daly PA
    Ann Oncol; 2003; 14 Suppl 3():iii19-25. PubMed ID: 12821534
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretest genetic counseling informs patients with BRCA mutation.
    Printz C
    Cancer; 2012 Dec; 118(24):6017. PubMed ID: 23208671
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.
    Leegte B; van der Hout AH; Deffenbaugh AM; Bakker MK; Mulder IM; ten Berge A; Leenders EP; Wesseling J; de Hullu J; Hoogerbrugge N; Ligtenberg MJ; Ardern-Jones A; Bancroft E; Salmon A; Barwell J; Eeles R; Oosterwijk JC
    J Med Genet; 2005 Mar; 42(3):e20. PubMed ID: 15744030
    [No Abstract]   [Full Text] [Related]  

  • 4. Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families.
    Woodward AM; Davis TA; Silva AG; Kirk JA; Leary JA;
    J Med Genet; 2005 May; 42(5):e31. PubMed ID: 15863663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk women should have BRCA testing.
    Cancer Discov; 2014 Feb; 4(2):139. PubMed ID: 24501290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Polygenic' analyses may sharpen disease risk predictions.
    Kaiser J
    Science; 2019 Dec; 366(6472):1431. PubMed ID: 31857459
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid screening test of most frequent BRCA1/BRCA2 pathogenic variants in the NGS era.
    Zidekova D; Waczulikova I; Dolesova L; Vavrova L; Hamidova O; Lohajova Behulova R; Konecny M
    Neoplasma; 2018; 65(2):309-315. PubMed ID: 29534594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAMA patient page. BRCA genes and breast cancer.
    Pluta RM; Golub RM
    JAMA; 2011 Jun; 305(21):2244. PubMed ID: 21632489
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
    Wolff TA; Wilson JE
    Am Fam Physician; 2006 Nov; 74(10):1759-60. PubMed ID: 17137007
    [No Abstract]   [Full Text] [Related]  

  • 11. Unprepared, understaffed, and unplanned: thoughts on the practical implications of discovering new breast and ovarian cancer causing genes.
    Resta RG
    J Genet Couns; 2009 Dec; 18(6):521-3. PubMed ID: 19798552
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
    Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counseling the at risk patient in the BRCA1 and BRCA2 Era.
    Barnes-Kedar IM; Plon SE
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):341-66, vii. PubMed ID: 12108833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic rearrangements in the BRCA1 and BRCA2 genes.
    Mazoyer S
    Hum Mutat; 2005 May; 25(5):415-22. PubMed ID: 15832305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 and BRCA2 cancer risks.
    Antoniou AC; Pharoah PD; Easton DF; Evans DG
    J Clin Oncol; 2006 Jul; 24(20):3312-3; author reply 3313-4. PubMed ID: 16829658
    [No Abstract]   [Full Text] [Related]  

  • 16. Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.
    James PA; Harris M; Lindeman GJ; Mitchell G
    J Med Genet; 2008 Nov; 45(11):765-6. PubMed ID: 18978334
    [No Abstract]   [Full Text] [Related]  

  • 17. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
    Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
    J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
    Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
    Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective.
    Foulkes WD
    Clin Genet; 2014 Jan; 85(1):1-4. PubMed ID: 24116874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.